• 1. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 2. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 3. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 4. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 5. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolopyridines Pyrrolopyridines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolopyridines

Recent Advances in the Application of 4-Chloro-7-methyl-5-azaindole (CAS: 1082040-95-6) in Chemical Biology and Pharmaceutical Research

4-Chloro-7-methyl-5-azaindole (CAS: 1082040-95-6) is a heterocyclic compound that has garnered significant attention in recent years due to its versatile applications in medicinal chemistry and drug discovery. This compound serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting kinase inhibition and other therapeutic pathways. Recent studies have highlighted its potential in the development of novel anticancer, anti-inflammatory, and antiviral agents, making it a focal point in contemporary pharmaceutical research.

One of the most notable applications of 4-Chloro-7-methyl-5-azaindole is its role as a building block in the synthesis of kinase inhibitors. Kinases are critical regulators of cellular signaling pathways, and their dysregulation is implicated in numerous diseases, including cancer and autoimmune disorders. Researchers have utilized this compound to develop selective inhibitors for kinases such as JAK, BTK, and EGFR, which are pivotal in oncology and immunology. The structural flexibility of 4-Chloro-7-methyl-5-azaindole allows for modifications that enhance binding affinity and selectivity, thereby improving therapeutic efficacy.

In a recent study published in the Journal of Medicinal Chemistry, scientists demonstrated the utility of 4-Chloro-7-methyl-5-azaindole in the design of potent JAK2 inhibitors. The study employed structure-activity relationship (SAR) analysis to optimize the compound's scaffold, resulting in derivatives with nanomolar inhibitory activity. These findings underscore the compound's potential in addressing unmet medical needs in myeloproliferative neoplasms and other JAK2-driven malignancies. Additionally, the study highlighted the compound's favorable pharmacokinetic properties, further supporting its clinical translatability.

Beyond kinase inhibition, 4-Chloro-7-methyl-5-azaindole has also been explored for its antiviral properties. A 2023 study in Antiviral Research reported the synthesis of novel derivatives targeting the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2. The researchers found that certain modifications of the 5-azaindole core significantly enhanced antiviral activity while maintaining low cytotoxicity. This discovery opens new avenues for the development of broad-spectrum antiviral agents, particularly in the context of emerging viral pathogens.

The synthetic accessibility of 4-Chloro-7-methyl-5-azaindole further contributes to its appeal in drug discovery. Recent advancements in green chemistry have enabled more sustainable and scalable synthesis routes, reducing environmental impact and production costs. For instance, a 2022 publication in Organic Process Research & Development detailed a novel catalytic method for the efficient preparation of this compound, emphasizing its compatibility with industrial-scale production. Such innovations are critical for accelerating the transition from bench to bedside.

In conclusion, 4-Chloro-7-methyl-5-azaindole (CAS: 1082040-95-6) represents a promising scaffold in chemical biology and pharmaceutical research. Its diverse applications in kinase inhibition, antiviral therapy, and other therapeutic areas highlight its versatility and potential for addressing complex medical challenges. Ongoing research efforts continue to uncover new opportunities for this compound, reinforcing its importance in the development of next-generation therapeutics. Future studies should focus on further optimizing its pharmacological properties and exploring its utility in combination therapies and personalized medicine approaches.

• 915778-09-5(1-chloro-4-methyl-5H-Pyrido[4,3-b]indol-8-amine)
• 1262681-43-5(11-Chloro-8-methyl-7H-benzo[e]pyrido[4,3-b]indol-3-ol)
• 139719-23-6(2-Chloro-6,8-dimethylquinoline)
• 649748-98-1(11H-Indolo[3,2-c]quinoline, 6-chloro-2-methyl-)
• 948291-23-4(2,5-dichloro-3,8-dimethyl-quinoline)
• 111380-53-1(1-chloro-4-methyl-5H-Pyrido[4,3-b]indol-8-ol)
• 4225-85-8(2-Chloro-8-methylquinoline)
• 111380-45-1(1-chloro-4-methyl-5H-Pyrido[4,3-b]indole)
• 106689-47-8(1-chloro-4-methyl-5H-Pyrrolo[3,2-c:4,5-c']dipyridine)
• 106689-49-0(1-chloro-4,5-dimethyl-5H-Pyrrolo[3,2-c:4,5-c']dipyridine)